Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...
-
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS,...
-
Emerging drugs market is expected to rise from $383.9 billion in 2024 to $558.0 billion by 2030, driven by faster regulations and increased R&D spending.
-
AGC Biologics expands its partnership with Novelty Nobility to manufacture a bispecific antibody in Japan.
-
- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive...
-
Enrollment completed in ML-007C-MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2...
-
The global GM foods market is projected to grow from $388.4 billion in 2025 to $451.6 billion by 2030, driven by rising food, feed, and protein demand.
-
SAN FRANCISCO, U.S. / LONDON, UK, April 30, 2026 (GLOBE NEWSWIRE) -- Living Carbon PBC, a climate technology company, has signed a major deal with leading specialist renewable investor Octopus...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and...
-
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care...